NHS England loses appeal – it must consider providing PrEP
Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV
Omega-3 fatty acids may reduce triglycerides and improve inflammation in people with HIV
Smoking more harmful than HIV for people taking effective treatment, US study suggests
Dolutegravir regimen highly effective in clinical trial for women
Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV
Men with HIV and men on PrEP in Boston see large increase in sexually transmitted infections
Four days on, three days off HIV treatment controls viral load in French pilot study
Do people living with HIV who have an undetectable viral load need to wear condoms?
